Clinical Trial Update: The NOR-SWITCH Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for NOR-SWITCH study; completed with multiple inflammatory diseases assessed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Spondyloarthritis
• Ulcerative Colitis

Snippet

Sponsor: Diakonhjemmet Hospital | Conditions: Rheumatoid Arthritis, Spondyloarthritis | Phase 4 | Status: COMPLETED